Content related to Developing New Approaches for Children With Cystic Fibrosis

A Children’s Hospital Los Angeles study has found that a virus that infects a common bacteria may lead to accelerated loss of lung function in individuals with cystic fibrosis (CF). The study

Dr. Burgener is exploring whether a tiny virus can help guide treatment for children with cystic fibrosis who have chronic airway infections.

Four investigators share their research—and how the USC/CHLA facility will help bring novel cell therapies to clinical trials faster.

Sally Ward, MD, received a lifetime achievement award from the American Thoracic Society for her contributions to pediatric pulmonology.

Dr. Joy Gibson is researching how to optimize the use of antibiotics and other strategies to manage infections in patients with cystic fibrosis.

Experts at Children’s Hospital Los Angeles and USC share how spatially fractionated radiation therapy and VMAT are enhancing radiation treatment for kids.

Born at 29 weeks, Sam suffered from subglottic stenosis, his airway so narrowed it was 95% closed. Doctors in CHLA’s Aerodigestive Program worked to rebuild it.

Dr. Shafali Jeste at Children’s Hospital Los Angeles is seeking biomarkers that can address the incredible variability of autism, an important step toward developing targeted treatments.

A clinical trial at CHLA is studying virus-specific T-cell therapy as a potential treatment for newborns with congenital cytomegalovirus.